AstraZeneca, Roche, Sanofi Raise 2024 Outlooks on Strong Q2 Sales

The three companies raised their respective full-year earnings forecasts on Thursday, buoyed by robust sales in the second quarter and their continued dominant market positions.

Scroll to Top